Abstract
We aimed to investigate the relationship between neurological compromise, respiratory parameters in wakefulness and in sleep, physiology, and morphology of phrenic nerves in patients with Charcot–Marie–Tooth disease type 1A (CMT1A). Sixteen patients with CMT1A were evaluated by spirometry, maximal expiratory and maximal inspiratory pressures (MEP, MIP), polysomnography, phrenic nerve compound muscle action potential (CMAP), and ultrasonography (roots C3,C4,C5 and phrenic nerves). Clinical disability was measured with Charcot–Marie–Tooth neuropathy score (CMT-NS; range 0–36). Two control groups, comprising 30 individuals matched for age, sex, and body mass index, were used for comparison. Ten patients were female (62 %), mean age was 37.88 years (range 24–76); and CMT-NS range was 7–34. MIP was reduced in five (31 %) and MEP in 12 patients (75 %), although only one had restrictive respiratory dysfunction in spirometry. Apnoea–hypopnea index (AHI) was significantly higher in patients (12.01 ± 11.57/h × 5.89 ± 8.36/h; p value = 0.05) and increased in REM sleep compared with NREM (9.94 ± 10.96/h × 19.13 ± 19.93/h; p value = 0.01). There were significant correlations between CMT-NS and AHI (Pearson = 0.69; p value = 0.03); CMT-NS and MIP (Pearson = −0.691, p value = 0.003); and CMT-NS and MEP (Pearson = −0.603, p value = 0.013). Also, AHI showed negative correlation with MIP (Pearson = −0.52, p value = 0.036) and MEP (Pearson = −0.55, p value = 0.026). Phrenic nerves were enlarged in ultrasonography in all patients and presented significant correlations with CMAPs (right: Pearson = −0.554, p value = 0.026; left: Pearson = −0.558, p value = 0.025). We suggest that axonal degeneration of nerves directed to muscles of respiration might explain the high prevalence of respiratory weakness in patients with CMT1A. Clinical manifestations are frequent during sleep, where the diaphragm alone can only partially surpass the overload in breathing apparatus.
Similar content being viewed by others
References
Braathen GJ (2012) Genetic epidemiology of Charcot–Marie–Tooth disease. Acta Neurol Scand 126(Suppl. 193):1–22
Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzetta V, Trask BJ, Saucedo-Cardenas O, Baker DF, Killian JM, Garcia CA, Chakravarti A, Patel PL (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232
Hoogendijk JE, De Visser M, Bour LJ, Ongerboer BW (1992) Conduction block in hereditary motor and sensory neuropathy type 1. Muscle Nerve 15:520–521
Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RHM, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120:465–478
Marques WJR, Freitas MR, Nascimento OJ, Oliveira AB, Calia L, Melo A, Lucena R, Rocha V, Barreira AA (2005) 17p duplicated Charcot–Marie–Tooth 1A: characteristics of a new population. J Neurol 252(8):972–979
Saporta ASD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME (2011) Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22–33
Reilly MM, Murphy SM, Laurá M (2011) Charcot–Marie–Tooth disease. J Peripher Nerv Syst 16:1–14
Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Forestier LEN, Agid Y, Brice A, Bouche P (1997) Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823
Garcia CM, Malamut RE, England JD, Parry GS, Liu P, Lupski JR (1995) Clinical variability in two pairs of identical twins with the Charcot–Marie–Tooth disease type 1A duplication. Neurology 45:2090–2093
Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinder SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A. Brain 123:1516–1527
Verhamme C, Van Schaik IN, Koelman JHTM, De Haan RJ, Vermeulen M, De Visser M (2004) Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 251:1491–1497
Chan CK, Mohsenin V, Loke J, Virgulto J, Sipski L, Ferranti R (1987) Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy. Chest 91(4):567–570
Dyer EL, Callahan AS III (1988) Charcot–Marie–Tooth disease and respiratory failure. Chest 92(1):221
Laroche CM, Carrol N, Moxham J, Stanley NN, Evans RJC, Green M (1988) Diaphragm weakness in Charcot–Marie–Tooth disease. Thorax 143:478–479
Hardie R, Harding AE, Hirsch N, Stanley NN, Evans RJC, Green M (1990) Diaphragmatic weakness in hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 53:348–350
Osanai S, Akiba Y, Nakano H, Matsumoto H, Yahara O, Onodera S (1992) Charcot–Marie–Tooth disease with diaphragmatic weakness. Intern Med 31(11):1267–1270
Gilchrist D, Chan CK, Deck JHN (1989) Phrenic involvement in Charcot–Marie–Tooth disease. Chest 96(5):1197–1199
Takakura Y, Furuya H, Yamashita K, Murai H, Araki T, Kikushi H, Ohiagy Y, Yamada T, Kira J (2002) A case of Charcot–Marie–Tooth disease (CMT) type 1 complicated by diabetes mellitus (DM) showing bilateral phrenic nerve palsy. Rinsho Shinkeigaku 42:320–322
Carter GT, Kilmer DD, Bonekat HW, Lieberman JS, Fowler WM (1992) Evaluation of phrenic nerve and pulmonary function in hereditary motor and sensory neuropathy, type I. Muscle Nerve 15:459–462
Eichacker PQ, Spiro A, Sherman M, Lazar E, Reichel J, Dodick F (1988) Respiratory muscle dysfunction in hereditary motor sensory neuropathy, type I. Arch Int Med 148:1739–1740
Maggi G, Bragadin MM, Padua L, Fiorina E, Bellone E, Grandis M, Lizia R, Benicelli A, Grosso M, Saporiti R, Scorsone D, Zuccarino R, Crimi E, Schenone A (2011) Outcome measures and rehabilitation treatment in patients affected by Charcot–Marie–Tooth neuropathy: a pilot study. Am J Phys Med Rehabil 90(8):628–637
Cruz-Martinez A, Armijo A, Fermoso A, Moraleda S, Maté I, Marín M (2000) Phrenic nerve conduction study in demyelinating neuropathies and open-heart surgery. Clin Neurophysiol 111:821–825
Sagliocco L, Orlandi G, Calabrese R, Pellegrinetti A, Baglini O, Castelli F, Baldinotti F, Sartucci F (2003) Electrodiagnostic evidence of phrenic nerve demyelination in Charcot–Marie–Tooth disease 1A. Am J Phys Med Rehabil 82(10):754–759
Dematteis M, Pépin JL, Jeanmart M, Deschaux C, Labarre-Villa A, Lévi P (2001) Charcot–Marie–Tooth disease and sleep apnoea syndrome: a family study. Lancet 57:267–272
Dziewas R, Waldmann N, Böntert M, Hor H, Müller T, Okegwo A, Ringelstein EB, Young P (2008) Increased prevalence of obstructive sleep apnoea in patients with Charcot–Marie–Tooth disease: a case control study. J Neurol Neurosurg Psychiatry 79:829–831
Boentert M, Knop K, Schuhmacher C, Gess B, Okegwo, Young P (2014) Sleep disorders in Charcot–Marie–Tooth disease type 1. J Neurol Neurosurg Psychiatry 85(3):319–325
Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214
American Thoracic Society (1987) Standardization of spirometry: 1987 update. Am Rev Respir Dis 136:1285–1298
ATS/ERS (2002) Joint statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624
Costa D, Gonçalves HA, Lima LP, Ike D, Cancelliero KM, Montebelo MI (2010) New reference values for maximal respiratory pressures in the Brazilian population. J Bras Pneumol 36(3):306–312
Iber C, Ancoli-Israel, Chesson A et al, for the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events. Rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14(6):540–545
Morélot-Panzini C, Fournier E, Donzel-Raynaud C, Dubourg O, Willer JC, Similowski T (2007) Conduction velocity of the human phrenic nerve in the neck. J Electromyogr Kinesiol 19(1):122–130
Bolton CF (2004) Clinical Neurophysiology of Breathing. In Bolton CF, Chen R, Wijdicks EFM, Zifko UA (eds) Neurology of breathing 2004, 1st edn. Butterworth-Heinemann, pp 75–107
Dionne A, Parkes A, Engler B, Watson BV, Nicolle MW (2009) Determination of the best electrode position for recording of the diaphragm compound muscle action potential. Muscle Nerve 40:37–41
Fromageot C, Lofaso F, Annane D, Falaize L, Lejaille M, Clair B, Gajdos P, Raphael JC (2001) Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil 82:123–128
Canella C, Demondion X, Delebarre A, Moraux A, Cotten H, Cotten A (2010) Anatomical study of phrenic nerve using ultrasound. Eur Radiol 20(3):659–665
Gibson GJ, Pride NB, Newson-Davis J, Loh C (1977) Pulmonary mechanics in patients with respiratory muscle weakness. Am Rev Respir Dis 115:389–395
Acknowledgments
We would like to thank Sandra Elizabete Marques for her technical support in our neurogenetic research laboratory (LNAE).
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical standard statement
All participants individually signed an informed consent. The study has been approved by the Ethics Committee for Medical Research of the University Hospital of Ribeirão Preto Medical School, University of São Paulo, SP, Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Junior, W.M., de Carvalho Alcântara, M., Nogueira-Barbosa, M.H. et al. Respiratory dysfunction in Charcot–Marie–Tooth disease type 1A. J Neurol 262, 1164–1171 (2015). https://doi.org/10.1007/s00415-015-7677-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7677-8